公开(公告)号：US20240316131A1

公开(公告)日：2024-09-26

申请号：US18575600

申请日：2022-06-30

申请人： AB Mauri (UK) Ltd

发明人： Carlos DE LECEA ,  Jordi CUÑÉ CASTELLANA ,  Maria TINTORÉ GAZULLA

IPC分类号： A61K36/064 ,  A61P1/00 ,  C12N1/16 ,  C12N1/18 ,  C12R1/645 ,  C12R1/85 ,  C12R1/865

CPC分类号： A61K36/064 ,  A61P1/00 ,  C12N1/165 ,  C12N1/185 ,  C12R2001/645 ,  C12R2001/85 ,  C12R2001/865

摘要： A physiologically acceptable composition comprising (i) at least one component selected from the group consisting of inactivated S. boulardii yeasts, S. boulardii lysates, S. boulardii cell wall components, and S. boulardii extracts, further comprising (ii) at least one component selected from the group of inactivated S. cerevisiae yeasts, S. cerevisiae lysates, S. cerevisiae cell wall components and S. cerevisiae extracts and further comprising (iii) at least one component selected from the group consisting of inactivated K. marxianus yeasts, K. marxianus lysates, K. marxianus cell wall components and K. marxianus extracts. The invention further relates to the composition for use as a medicament, as a food additive or functional ingredient for nutraceuticals, food for special medical purposes, cosmeceuticals and functional foods, and as a feed additive of functional ingredient in animal nutrition, as ingredient for topical application.

公开(公告)号：US20240293488A1

公开(公告)日：2024-09-05

申请号：US18575656

申请日：2022-06-30

申请人： AB Mauri (UK) Ltd

发明人： Carlos DE LECEA ,  Jordi CUÑÉ CASTELLANA ,  Maria TINTORÉ GAZULLA

IPC分类号： A61K36/064 ,  A61P1/14 ,  C12N1/20 ,  C12R1/85

CPC分类号： A61K36/064 ,  A61P1/14 ,  C12N1/205 ,  C12R2001/85

摘要： A physiologically acceptable composition comprising (i) at least one component selected from the group consisting of S. boulardii yeasts, S. boulardii lysates, S. boulardii cell wall components, and S. boulardii extracts, further comprising (ii) at least one component selected from the group of S. cerevisiae yeasts, S. cerevisiae lysates, S. cerevisiae cell wall components and S. cerevisiae extracts and further comprising (iii) at least one component selected from the group consisting of K. marxianus yeasts, K. marxianus lysates, K. marxianus cell wall components and K. marxianus extracts. The invention further relates to the composition for use as a medicament, as a food additive or functional ingredient for nutraceuticals, food for special medical purposes, cosmeceuticals and functional foods, and as a feed additive of functional ingredient in animal nutrition, as ingredient for topical application.

公开(公告)号：US20240325475A1

公开(公告)日：2024-10-03

申请号：US18575677

申请日：2022-06-30

申请人： AB Mauri (UK) Ltd

发明人： Carlos DE LECEA ,  Jordi CUÑÉ CASTELLANA ,  Maria TINTORÉ GAZULLA

IPC分类号： A61K36/064 ,  A61P1/00 ,  A61P31/14

CPC分类号： A61K36/064 ,  A61P1/00 ,  A61P31/14

摘要： A physiologically acceptable composition comprising at least one component selected from the group consisting of S. boulardii yeasts, S. boulardii lysates, S. boulardii cell wall components, and S. boulardii extracts, further comprising at least one component selected from the group consisting of K. marxianus yeasts, K. marxianus lysates, K. marxianus cell wall components and K. marxianus extracts. Optionally, the composition further comprises at least one component selected from the group of S. cerevisiae yeasts, S. cerevisiae lysates, S. cerevisiae cell wall components and S. cerevisiae extracts. The invention further relates to the composition for use as a medicament.